Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 3/20 | 0.74 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.57 |
| ▸ | NAT1 | P18440 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | COMT | P21964 | 1/20 | 0.56 |
| ▸ | IGF1R | P08069 | 2/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | TDP2 | O95551 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | CASP9 | P55211 | 1/20 | 0.53 |
| ▸ | CASP6 | P55212 | 1/20 | 0.53 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.53 |
| ▸ | XDH | P47989 | 2/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8049587 | 1.00 | GSK3B (0.74) | GSK3BCISD1NAT1MAOAMAOB | |
| SCHEMBL8051034 | 0.87 | TDP1 (0.59) | GSK3BCOMTTDP2XDHTDP1 | |
| SCHEMBL8051036 | 0.87 | TDP1 (0.59) | GSK3BCOMTTDP2XDHTDP1 | |
| SCHEMBL8038859 | 0.87 | GSK3B (0.74) | GSK3BCISD1NAT1COMTPTGS2 | |
| SCHEMBL8038857 | 0.87 | GSK3B (0.74) | GSK3BCISD1NAT1COMTPTGS2 | |
| SCHEMBL9015992 | 0.87 | XDH (0.63) | GSK3BCOMTXDHHPGD | |
| SCHEMBL9015993 | 0.87 | XDH (0.63) | GSK3BCOMTXDHHPGD | |
| SCHEMBL9831869 | 0.85 | GSK3B (1.00) | GSK3BCISD1IGF1RTDP2CASP7 | |
| SCHEMBL4852830 | 0.85 | GSK3B (0.81) | GSK3BCISD1IGF1RTDP2CASP7 | |
| SCHEMBL9831864 | 0.85 | GSK3B (1.00) | GSK3BCISD1IGF1RTDP2CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5614541-A | MEDICINAL ANTIOXIDANTS, REDUCING CELL DAMAGE CAUSED BY OXYGEN DERIVED RADICALS | Orion-yhtym a Oy (FI) | 1997-03-25 | — | — | US | claimed |
| EP-0526598-B1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | ORION YHTYMAE OY (FI) | 1996-12-18 | — | — | EP | claimed |
| EP-0526598-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES. | ORION YHTYMAE OY (FI) | 1993-02-10 | — | — | EP | claimed |
| WO-1991017151-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | Orion-Yhtymä Oy (FI) | 1991-11-14 | — | — | WO | claimed |
| US-6121303-A | SUCH AS 4-((3,4-DIHYDROXY-5-NITROPHENYL)METHYLIDENE)-2,5-IMIDAZOLIDINDIONE; MEDICINAL ANTIOXIDANTS FOR TREATMENT OR PREVENTION OF TISSUE DAMAGE CAUSED BY LIPID PEROXIDATION | ORION-YHTYMA OY (FI) | 2000-09-19 | — | — | US | disclosed |
| US-5889037-A | PREVENTION, THERAPY TISSUE DAMAGE FROM LIPID PEROXIDATION | ORION-YHTYMA OY (FI) | 1999-03-30 | — | — | US | disclosed |
| US-5614541-A | MEDICINAL ANTIOXIDANTS, REDUCING CELL DAMAGE CAUSED BY OXYGEN DERIVED RADICALS | Orion-yhtym a Oy (FI) | 1997-03-25 | — | — | US | disclosed |
| EP-0526598-B1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | ORION YHTYMAE OY (FI) | 1996-12-18 | — | — | EP | disclosed |
| US-5362733-A | Lipid peroxidation prevention | ORION-YHTYMA OY (FI) | 1994-11-08 | — | — | US | disclosed |
| EP-0526598-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES. | ORION YHTYMAE OY (FI) | 1993-02-10 | — | — | EP | disclosed |
| WO-1991017151-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | Orion-Yhtymä Oy (FI) | 1991-11-14 | — | — | WO | disclosed |